FocusCancer Immunotherapy

Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer

See allHide authors and affiliations

Science Signaling  17 Jan 2017:
Vol. 10, Issue 462, eaal2328
DOI: 10.1126/scisignal.aal2328

Article Information

vol. 10 no. 462

PubMed: 
Published By: 
Print ISSN: 
Online ISSN: 
History: 
  • .

Author Information

  1. Xin Chen1,2,* and
  2. Joost J. Oppenheim2,*
  1. 1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao S.A.R. 999078, China.
  2. 2Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.
  1. *Corresponding author. Email: xchen{at}umac.mo (X.C.); oppenhej{at}mail.nih.gov (J.J.O.)

Altmetric

Article usage

Article usage: January 2017 to August 2020

AbstractFullPdf
Jan 20175477189364
Feb 201768870134
Mar 20175192572
Apr 20174932753
May 20174662758
Jun 20173641334
Jul 20172641319
Aug 2017198422
Sep 20171961930
Oct 20171971735
Nov 20172151933
Dec 20171181019
Jan 20181671713
Feb 20181051219
Mar 20181352026
Apr 20181892638
May 20181951422
Jun 2018116815
Jul 20181062018
Aug 2018833615
Sep 2018913113
Oct 20181163813
Nov 2018116339
Dec 201868189
Jan 2019853514
Feb 201987186
Mar 20191293418
Apr 2019432612
May 201939158
Jun 201928117
Jul 201924177
Aug 201938226
Sep 20193893
Oct 2019923114
Nov 201942259
Dec 20194085
Jan 202032182
Feb 202036105
Mar 20203875
Apr 2020541411
May 20202864
Jun 20204061
Jul 20202874
Aug 20201285

Stay Connected to Science Signaling